Wakefield Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,638
Closed -$484K 229
2026
Q1
$484K Sell
1,638
-16
-1% -$4.75K 0.13% 177
2025
Q4
$452K Buy
1,654
+76
+5% +$20.7K 0.12% 170
2025
Q3
$426K Sell
1,578
-5,401
-77% -$1.47M 0.12% 160
2025
Q2
$1.92M Sell
6,979
-238
-3% -$64.7K 0.54% 54
2025
Q1
$1.91M Buy
7,217
+4,985
+223% +$1.23M 0.58% 51
2024
Q4
$518K Buy
2,232
+724
+48% +$166K 0.18% 129
2024
Q3
$333K Buy
1,508
+17
+1% +$3.52K 0.11% 141
2024
Q2
$293K Buy
1,491
+87
+6% +$18K 0.1% 142
2024
Q1
$302K Sell
1,404
-627
-31% -$132K 0.1% 143
2023
Q4
$428K Buy
2,031
+710
+54% +$151K 0.16% 135
2023
Q3
$264K Buy
+1,321
New +$263K 0.12% 144

Other funds holding CME

Wakefield Asset Management's CME Position: Q2 2026 in Review

Wakefield Asset Management sold out of CME Group (CME) in Q2 2026, closing a stake of 1,638 shares — an estimated $484K sold.

Wakefield Asset Management first reported a position in CME in Q3 2023 and held it in 11 quarters. The position peaked at $1.92M in Q2 2025. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Wakefield Asset Management reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Wakefield Asset Management sold 1,638 CME Group shares in Q2 2026, an estimated $484K.
  • Wakefield Asset Management first reported a position in CME Group in Q3 2023 and held it in 11 quarters.
  • Wakefield Asset Management's CME Group position peaked at $1.92M in Q2 2025.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.